$300-500M to bring TAVR to the market???? The development cost of the product has already been done with the clinical trials currently occurring, possibly need $50M for commercialisation if AVR plan to go it alone again like what they did with ADAPT but IMO WP has learnt that to get into the surgery medical device market, the best strategy is to partner with existing company as they've already generated the market brand after many years.
AVR Price at posting:
$4.80 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)